We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Yervoy Bristol-Myers Squibb Australia Pty Ltd
Product name
Yervoy
Accepted date
Jul-2024
Active ingredients
Ipilimumab
Proposed indication
YERVOY in combination with nivolumab is indicated for the treatment of patients with unresectable or metastatic colorectal cancer
Application type
C (new indication)
Publication date
Jul-2024